According to Bristol-Myers Squibb's latest financial reports and stock price the company's current Operating Margin is -17.34%. At the end of 2024 the company had an Operating Margin of -17.35%.
Year | Operating Margin | Change |
---|---|---|
2024 | -17.35% | -192.51% |
2023 | 18.75% | 12.23% |
2022 | 16.71% | -4.29% |
2021 | 17.46% | -208.03% |
2020 | -16.16% | -184.93% |
2019 | 19.03% | -28.07% |
2018 | 26.45% | 7.11% |
2017 | 24.70% | -18.89% |
2016 | 30.45% | 142.76% |
2015 | 12.54% | -16.36% |
2014 | 14.99% | -15.02% |
2013 | 17.64% | 32.87% |
2012 | 13.28% | -59.59% |
2011 | 32.86% | 5.46% |
2010 | 31.16% | 4.61% |
2009 | 29.79% | 10.48% |
2008 | 26.96% | 47.6% |
2007 | 18.27% | 31.33% |
2006 | 13.91% | -39.88% |
2005 | 23.13% | 1.48% |
2004 | 22.80% | -9.14% |
2003 | 25.09% | 64.53% |
2002 | 15.25% | 23.66% |
2001 | 12.33% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.